Advances in the design and delivery of RNA vaccines for infectious diseases.
Lokras AG, Bobak TR, Baghel SS, Sebastiani F, Foged C.
Adv Drug Deliv Rev. 2024 Oct;213:115419. doi: 10.1016/j.addr.2024.115419. Epub 2024 Aug 5.
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies.
Andrews CD, Huang Y, Ho DD, Liberatore RA.
Emerg Microbes Infect. 2020 Dec;9(1):1523-1533. doi: 10.1080/22221751.2020.1787108.
[HIV and pregnancy].
Zweifel VB, Berger C, Nadal D, Grawe C.
Ther Umsch. 2014 Aug;71(8):498-502. doi: 10.1024/0040-5930/a000543.
CRISPR-based strategies in infectious disease diagnosis and therapy.
Binnie A, Fernandes E, Almeida-Lousada H, de Mello RA, Castelo-Branco P.
Infection. 2021 Jun;49(3):377-385. doi: 10.1007/s15010-020-01554-w. Epub 2021 Jan 3.
DNA vaccines: prime time is now.
Gary EN, Weiner DB.
Curr Opin Immunol. 2020 Aug;65:21-27. doi: 10.1016/j.coi.2020.01.006. Epub 2020 Apr 4.
Antiretroviral Options and Treatment Decisions During Pregnancy.
Poliektov NE, Badell ML.
Paediatr Drugs. 2023 May;25(3):267-282. doi: 10.1007/s40272-023-00559-w. Epub 2023 Feb 2.
Coronavirus disease 2019 during pregnancy: a systematic review of reported cases.
Della Gatta AN, Rizzo R, Pilu G, Simonazzi G.
Am J Obstet Gynecol. 2020 Jul;223(1):36-41. doi: 10.1016/j.ajog.2020.04.013. Epub 2020 Apr 18.
Spotlight on avian pathology: the importance of recombinant vector platform technologies in poultry vaccination.
Francis MJ.
Avian Pathol. 2021 Apr;50(2):109-111. doi: 10.1080/03079457.2021.1875624. Epub 2021 Feb 8.
Hybrid Nanosystems of Antibiotics with Metal Nanoparticles-Novel Antibacterial Agents.
Shabatina TI, Vernaya OI, Melnikov MY.
Molecules. 2023 Feb 7;28(4):1603. doi: 10.3390/molecules28041603.
mRNA: A Novel Avenue to Antibody Therapy?
Schlake T, Thran M, Fiedler K, Heidenreich R, Petsch B, Fotin-Mleczek M.
Mol Ther. 2019 Apr 10;27(4):773-784. doi: 10.1016/j.ymthe.2019.03.002. Epub 2019 Mar 6.
